UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007932
Receipt number R000009340
Scientific Title Quality of life study of palonosetron and dexamethasone in chemonaive patinets with advanced colorectal cancer treated with moderateemetic chemotherapy
Date of disclosure of the study information 2012/05/11
Last modified on 2016/11/14 21:20:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Quality of life study of palonosetron and dexamethasone in chemonaive patinets with advanced colorectal cancer treated with moderateemetic chemotherapy

Acronym

Palonosetoron and dexamethasone QOL study

Scientific Title

Quality of life study of palonosetron and dexamethasone in chemonaive patinets with advanced colorectal cancer treated with moderateemetic chemotherapy

Scientific Title:Acronym

Palonosetoron and dexamethasone QOL study

Region

Japan


Condition

Condition

advanced colorectal cancer recieving moterate emetic chemotherapy

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of palonosetoron and dexamethasone in patients recieving moderate emetic chemotherapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

MAT(MASCC Antiemesis Tool)
QOL-ACD(The QOL Questionnaire for Cancer Patients Treated with Anticancer Drugs)

Key secondary outcomes

safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

palonosetoron and dexamethasone

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1. Age; more than 20 years-old
2. Histologicaly proven colorectal cancer
3. Chemotherapy naive
4. Patients recieving moderate emetic chemorerapy including oxaliplatin or irinotecan
5. Adequate organ function as follows: WBC > 3000/mm3, AST < 100IU/L, ALT < 100IU/L
6. Perfomance Status(ECOG): 0-2
7. Written informed consent

Key exclusion criteria

1. Uncontrolled severe complication disease, such as ileus, idiopatic pulmomary fibrosis, daibetes, cardiac infarction, angina pectoris, renal failure, hepatic failure, mental disorder, cerebral vansular disease, active gastrointestinal tract ulcer.
2. Symptomatic brain metastasis
3. Epilepsy patint treated with antiepileptic agent, exclusing being stable clinically
4. Patient with massive pleural effusion or ascitis to be required dranage
5. Obstruction of the gastric outlet or ileus
6.Grade 2 or more nausea and vomiting
7.Anaphylaxis to palonosetron or dexamethasone
8. Patients treated with 5-HT3 antagonist, NK1 antagonist, SSRI, SNRI
9.Patient not to use birth contorol
10. Unsuitable patients by investigator

Target sample size

110


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koji Takeda

Organization

Osaka City General Hospital

Division name

Department of Clinical Oncology

Zip code


Address

2-13-22, Miyakojimahondohri, Miyakojima-ku, Osaka, Japan

TEL

06-6929-1221

Email

kkk-take@ga2.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Koji Takeda

Organization

Osaka City General Hospital

Division name

Department of Clinical Oncology

Zip code


Address

2-13-22, Miyakojimahondohri, Miyakojima-ku, Osaka, Japan

TEL

06-6929-1221

Homepage URL


Email

kkk-take@ga2.so-net.ne.jp


Sponsor or person

Institute

Osaka City General Hospital

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立総合医療センター


Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 09 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2014 Year 08 Month 31 Day

Date of closure to data entry

2014 Year 10 Month 31 Day

Date trial data considered complete

2014 Year 11 Month 30 Day

Date analysis concluded

2015 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 05 Month 11 Day

Last modified on

2016 Year 11 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009340


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name